These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21401349)

  • 1. BMI, spKt/V, and SBP but not DBP are related to LVH in Chinese maintenance hemodialysis patients.
    Cao X; Zou J; Teng J; Zhong Y; Ji J; Chen Z; Liu Z; Shen B; Ding X
    Ren Fail; 2011; 33(3):269-75. PubMed ID: 21401349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants.
    Zhao X; Zhu L; Jin W; Yang B; Wang Y; Ni M; Zhao Y; Gan L; Zuo L
    BMC Cardiovasc Disord; 2022 Feb; 22(1):55. PubMed ID: 35172749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood pressures values during evaluation of 24-h ambulatory blood pressure monitoring and left ventricular hypertrophy in patients with chronic renal failure treated with hemodialysis (HD)].
    Wanic-Kossowska M; Leman P; Kobelski M; Czekalski S
    Pol Arch Med Wewn; 2002 Jan; 107(1):29-35. PubMed ID: 12046341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients.
    Fagugli RM; Pasini P; Quintaliani G; Pasticci F; Ciao G; Cicconi B; Ricciardi D; Santirosi PV; Buoncristiani E; Timio F; Valente F; Buoncristiani U
    Nephrol Dial Transplant; 2003 Nov; 18(11):2332-8. PubMed ID: 14551362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, fluid overload and micro inflammation are associated with left ventricular hypertrophy in maintenance hemodialysis patients.
    Xu Y; Chen Y; Li D; Li J; Liu X; Cui C; Yu C
    Ren Fail; 2013 Oct; 35(9):1204-9. PubMed ID: 23901794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
    BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients.
    Moon KH; Song IS; Yang WS; Shin YT; Kim SB; Song JK; Park JS
    Am J Nephrol; 2000; 20(5):396-401. PubMed ID: 11092998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.
    Mitsnefes MM; Daniels SR; Schwartz SM; Meyer RA; Khoury P; Strife CF
    Pediatr Nephrol; 2000 Sep; 14(10-11):898-902. PubMed ID: 10975295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular mass relates to average systolic blood pressure, but not loss of circadian blood pressure in stable hemodialysis patients: an ambulatory 48-hour blood pressure study.
    Nishikimi T; Minami J; Tamano K; Takahashi M; Numabe A; Futoo Y; Honda T; Kobayashi T; Uetake S; Mori Y; Saito T; Matsuoka H
    Hypertens Res; 2001 Sep; 24(5):507-14. PubMed ID: 11675944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
    Patel RK; Oliver S; Mark PB; Powell JR; McQuarrie EP; Traynor JP; Dargie HJ; Jardine AG
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1477-1483. PubMed ID: 19713289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of dialysis adequacy, body mass index, and mortality among hemodialysis patients.
    Hong WP; Lee YJ
    BMC Nephrol; 2019 Oct; 20(1):382. PubMed ID: 31640580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention.
    Levin A; Singer J; Thompson CR; Ross H; Lewis M
    Am J Kidney Dis; 1996 Mar; 27(3):347-54. PubMed ID: 8604703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis].
    Wanic-Kossowska M; Lehmann P; Czekalski S
    Pol Arch Med Wewn; 2002 Jun; 107(6):539-46. PubMed ID: 12375575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy and LV geometry in chronic dialysis children and adolescents.
    Lumpaopong A; Tuntrakool C; Thirakhupt P; Chulamokha Y
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S202-5. PubMed ID: 16858959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
    Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
    Hsu HJ; Wu MS
    Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.